Novolog (Pharm-Up 1966) Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	222.2	247.6	232.94	172.81	238.71	176.44
Cash & Short-Term Investments	222.2	247.6	232.94	172.81	238.71	176.44
Cash Growth	-7.40%	6.29%	34.80%	-27.61%	35.29%	-4.68%
Accounts Receivable	1,817	1,744	1,560	1,310	1,286	1,260
Other Receivables	64.5	46.62	53.43	36.54	20.28	10.99
Receivables	1,881	1,790	1,613	1,346	1,306	1,271
Inventory	269.48	315.08	247.33	189.03	186.79	255.64
Prepaid Expenses	-	7.57	11.35	9.56	10.25	4.68
Other Current Assets	36.22	8.25	1.86	0.76	-	-
Total Current Assets	2,409	2,369	2,106	1,719	1,742	1,708
Property, Plant & Equipment	273.59	297.54	321.4	306.62	224.77	191.24
Long-Term Investments	14.43	13.61	16.2	42.31	23.4	0.5
Goodwill	149.05	156.2	162.69	206.96	161.06	144.91
Other Intangible Assets	173.17	159.25	138.43	121.92	97.4	75.78
Long-Term Accounts Receivable	24.43	26.11	29.62	32.15	33.94	34.93
Long-Term Deferred Tax Assets	7.8	3.74	4.82	1.78	0.77	1.04
Other Long-Term Assets	8.39	11.85	9	6.29	5.04	30.2
Total Assets	3,060	3,037	2,789	2,437	2,289	2,187
Accounts Payable	2,354	2,357	2,079	1,662	1,616	1,663
Accrued Expenses	-	64.5	56.53	49.43	43.48	32.97
Current Portion of Long-Term Debt	23	-	0.91	1.15	0.39	0.06
Current Portion of Leases	26.17	21.31	26.6	22.06	20.14	16.2
Current Income Taxes Payable	7.16	6.03	6.55	6.52	4.59	2.61
Other Current Liabilities	95.6	13.66	15.65	13.42	4.3	18.39
Total Current Liabilities	2,506	2,462	2,185	1,754	1,689	1,734
Long-Term Debt	-	-	0.07	0.97	0.92	0.43
Long-Term Leases	160.34	177.16	187.59	188.6	145.37	137.54
Pension & Post-Retirement Benefits	1.3	1.41	1.88	2.01	3.75	2.59
Long-Term Deferred Tax Liabilities	8.37	12.94	16.41	19.71	17.63	16.22
Other Long-Term Liabilities	-	1.18	1.69	6.46	1.42	0.5
Total Liabilities	2,676	2,655	2,392	1,972	1,858	1,891
Common Stock	5.11	5.11	5.11	5.09	5.07	4.64
Additional Paid-In Capital	347.48	347.19	345.07	340.97	339.73	218.91
Retained Earnings	31.95	32.21	32.67	91.58	75.97	65.65
Comprehensive Income & Other	-12.53	-16.13	-11.77	-1.93	3.61	5.49
Total Common Equity	372.01	368.38	371.08	435.7	424.37	294.69
Minority Interest	12.03	13.77	25.04	28.78	5.86	0.98
Shareholders' Equity	384.05	382.14	396.12	464.48	430.23	295.67
Total Liabilities & Equity	3,060	3,037	2,789	2,437	2,289	2,187
Total Debt	209.52	198.47	215.18	212.77	166.81	154.24
Net Cash (Debt)	12.68	49.13	17.76	-39.97	71.9	22.2
Net Cash Growth	-65.35%	176.64%	-	-	223.81%	-18.03%
Net Cash Per Share	0.02	0.10	0.03	-0.08	0.14	0.05
Filing Date Shares Outstanding	510.87	510.75	510.72	508.7	506.57	463.49
Total Common Shares Outstanding	510.87	510.75	510.72	508.7	506.57	463.49
Working Capital	-96.81	-93.45	-78.39	-35.81	52.94	-25.64
Book Value Per Share	0.73	0.72	0.73	0.86	0.84	0.64
Tangible Book Value	49.79	52.93	69.97	106.82	165.91	74
Tangible Book Value Per Share	0.10	0.10	0.14	0.21	0.33	0.16
Machinery	-	145.73	148.01	131.88	155.63	133.06
Leasehold Improvements	-	134.68	131.41	113.03	74.47	71

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.